Corneal Persistent Epithelial Defect clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • KPI-012 Ophthalmic Solution in Participants With PCED

    open to eligible people ages 18 years and up

    The primary objective of the study is to investigate the safety and efficacy of KPI-012 compared to vehicle in participants who have a documented clinical diagnosis of PCED.

    Los Angeles, California and other locations

Our lead scientists for Corneal Persistent Epithelial Defect research studies include .

Last updated: